Report cover image

United States Home Infusion Market, Size, Global Forecast 2023-2027, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

Publisher Renub Research
Published Nov 01, 2022
Length 150 Pages
SKU # RNBR17540063

Description

United States Home Infusion Market, Size, Global Forecast 2023-2027, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

United States Home Infusion Market will reach US$ 20.6 Billion by 2027 according to Renub Research. Home infusion is a clinically suitable treatment option for patients with a wide array of chronic and acute conditions, ranging from bacterial infections to progressively complex conditions like immune deficiencies, nutrition support, bleeding disorders, and late-stage heart failure. Home infusion can afford patients liberty and better quality of life since it is offered in the comfort of the patient's home, effectively fitting their needs. It also gives better outcomes, provides enhanced safety, and is cost-effective.

The increasing geriatric population susceptible to chronic diseases and rising prevalence of urinary tract infections will boost the market growth:

The rapidly growing old-aged population in the United States is one of the main drivers of market growth. For instance, according to data issued by the United States Department of Health and Human Services, there are more than 49.2 million individuals above 65 years of age across the country. Moreover, the number of graying Americans has risen by around 33% over the past decennium. Therefore, as home infusion therapy aids in managing chronic conditions of the elderly populace, the market will witness significant growth in the future.

According to a recent news article, urinary tract infections contribute to about 6 million patient visits to physicians each year in the United States Thus, a large patient pool requiring home infusion therapy will generate high demand over the analyzed period. In addition, the acceptance of new technologies in the home infusion therapy market will support the industry's growth.

United States Home Infusion Market is expected to grow with a CAGR of 7.88% from 2022 to 2027

Amongst other segments, an infusion pump holds a significant share in 2022. This can be attributed to their efficiency and increasing use in delivering medications, nutrition, and other required fluids in required amounts. Needleless connectors is anticipated to be the fastest-growing segment over the forecast period owing to various benefits, such as higher protection against needlestick injuries and less risk of bacterial contamination. In addition, needleless connectors reduce the risk of Healthcare Associated Bloodstream Infections. Owing to these features, the demand for needleless connectors is predicted to augment over the forecast period.

Indication Insights:

Based on Indication, the U.S. home infusion therapy market is categorized into Anti-infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Parenteral Nutrition, Immunoglobulins, and Others. Hydration therapy provides several benefits, such as boosting immunity and reduced recovery time. It also improves cognitive functions, flushes toxins from the body, is efficient, it tends to strengthen joint, skin, and muscle health.

COVID-19 Impact on U.S. Home Infusion Therapy Market:

The COVID-19 pandemic has positively impacted the Industry. The U.S. Key players reported a significant growth in revenues from services, devices, and drugs, owing to the considerable increase in patients receiving infusion therapy at home during COVID-19 restrictions. For instance, Option Care Health, Inc. generated USD 3,302.6 million in 2020 and witnessed a 30.1% increase in its revenue in 2020 compared to 2019. The growth was attributable to increased demand for its home infusion therapy services.

Furthermore, In October 2020, the Centers for Medicare & Medicaid Services (CMS) announced a proposed rule broadening coverage for home infusion Durable Medical Equipment (DME), specifically for external infusion pumps, to increase access to home infusion drugs. Moreover, with the COVID-19 outbreak, home-infusion solutions have become more critical than ever, allowing patients to remain in their homes, thereby decreasing the risk of exposure. Hence, various local infusion service providers witnessed a surge in demand for home-based services.

Key Players:

CVS Health, Becton, Dickinson and Company, Smith & Nephew plc, Terumo Corporation, ICU Medical, Moog, and InfuSystems Holdings are the leading competitors in the U.S. home infusion therapy market. Further, these organizations employ various techniques to drive their company portfolio worldwide, including innovative product releases and R&D.

Renub Research latest report “U.S. Home Infusion Therapy Market, Forecast By Product (Home Infusion Device, Home Infusion Drugs, Home Infusion Services), Product Type (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), Indication (Anti-infective, Chemotherapy, HydrationTherapy, EnteralNutrition, Parenteral Nutrition, Immunoglobulins, Others), Zone ( East North Central, West South Central, South Atlantica, North East, East South Central, West North Centre, Pacific Central, Mountain States,) Companies (CVS Health, Becton, Dickinson and Company, Smith & Nephew plc, Terumo Corporation, ICU Medical, Moog, InfuSystems Holdings)” provides a detailed analysis of U.S. Home Infusion Therapy Industry.

Product – The market has been studied from 3 viewpoints:

1. Home Infusion Device
2. Home Infusion Drugs
3. Home Infusion Services

Product Type – The market has been studied from 4 viewpoints:

1. Infusion Pump
2. Intravenous Sets
3. IV Cannulas
4. Needleless Connectors

Indication – The market has been studied from 7 viewpoints:

1. Anti-infective
2. Chemotherapy
3. Hydration Therapy
4. Enteral Nutrition
5. Parenteral Nutrition
6. Immunoglobulins
7. Others

Zone – The market has been studied from 8 viewpoints:

1. East North Central
2. West South Central
3. South Atlantica
4. North East
5. East South Central
6. West North Centre
7. Pacific Central
8. Mountain States

Company Insights:

• Overview
• Initiatives/Recent Developments
• Financial Insight

Companies Covered:

1. CVS Health
2. Becton, Dickinson and Company
3. Smith & Nephew plc
4. Terumo Corporation
5. ICU Medical
6. Moog
7. InfuSystems Holdings

Table of Contents

150 Pages
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. United States Home Infusion Therapy Market
6. Market Share – United States Home Infusion Therapy Market
6.1 By Product
6.2 By Product Type
6.3 By Indication
6.4 By Zone
7. Product – United States Home Infusion Therapy Market
7.1 Home Infusion Device
7.2 Home Infusion Drugs
7.3 Home Infusion Services
8. Product Type – United States Home Infusion Therapy Market
8.1 Infusion Pump
8.2 Intravenous Sets
8.3 IV Cannulas
8.4 Needleless Connectors
9. Indication – United States Home Infusion Therapy Market
9.1 Anti-infective
9.2 Chemotherapy
9.3 Hydration Therapy
9.4 Enteral Nutrition
9.5 Parenteral Nutrition
9.6 Immunoglobulins
9.7 Others
10. Zone – United States Home Infusion Therapy Market
10.1 East North Central
10.2 West South Central
10.3 South Atlantica
10.4 North East
10.5 East South Central
10.6 West North Centre
10.7 Pacific Central
10.8 Mountain States
11. Key Players
11.1 CVS Health
11.1.1 Overview
11.1.2 Recent Development
11.1.3 Revenue
11.2 Becton, Dickinson and Company
11.2.1 Overview
11.2.2 Recent Development
11.2.3 Revenue
11.3 Smith & Nephew plc
11.3.1 Overview
11.3.2 Recent Development
11.3.3 Revenue
11.4 Terumo Corporation
11.4.1 Overview
11.4.2 Recent Development
11.4.3 Revenue
11.5 ICU Medical
11.5.1 Overview
11.5.2 Recent Development
11.5.3 Revenue
11.6 Moog
11.6.1 Overview
11.6.2 Recent Development
11.6.3 Revenue
11.7 InfuSystems Holdings
11.7.1 Overview
11.7.2 Recent Development
11.7.3 Revenue
List of Figures:
Figure-01: United States – Home Infusion Therapy Market (Million US$), 2017 – 2022
Figure-02: United States – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
Figure-03: Product – Home Infusion Device Market (Million US$), 2017 – 2022
Figure-04: Product – Forecast for Home Infusion Device Market (Million US$), 2023 – 2027
Figure-05: Product – Home Infusion Drugs Market (Million US$), 2017 – 2022
Figure-06: Product – Forecast for Home Infusion Drugs Market (Million US$), 2023 – 2027
Figure-07: Product – Home Infusion Services Market (Million US$), 2017 – 2022
Figure-08: Product – Forecast for Home Infusion Services Market (Million US$), 2023 – 2027
Figure-09: Product Type – Infusion Pump Market (Million US$), 2017 – 2022
Figure-10: Product Type – Forecast for Infusion Pump Market (Million US$), 2023 – 2027
Figure-11: Product Type – Intravenous Sets Market (Million US$), 2017 – 2022
Figure-12: Product Type – Forecast for Intravenous Sets Market (Million US$), 2023 – 2027
Figure-13: Product Type – IV Cannulas Market (Million US$), 2017 – 2022
Figure-14: Product Type – Forecast for IV Cannulas Market (Million US$), 2023 – 2027
Figure-15: Product Type – Needleless Connectors Market (Million US$), 2017 – 2022
Figure-16: Product Type – Forecast for Needleless Connectors Market (Million US$), 2023 – 2027
Figure-17: Indication – Anti-infective Market (Million US$), 2017 – 2022
Figure-18: Indication – Forecast for Anti-infective Market (Million US$), 2023 – 2027
Figure-19: Indication – Chemotherapy Market (Million US$), 2017 – 2022
Figure-20: Indication – Forecast for Chemotherapy Market (Million US$), 2023 – 2027
Figure-21: Indication – Hydration Therapy Market (Million US$), 2017 – 2022
Figure-22: Indication – Forecast for Hydration Therapy Market (Million US$), 2023 – 2027
Figure-23: Indication – Enteral Nutrition Market (Million US$), 2017 – 2022
Figure-24: Indication – Forecast for Enteral Nutrition Market (Million US$), 2023 – 2027
Figure-25: Indication – Parenteral Nutrition Market (Million US$), 2017 – 2022
Figure-26: Indication – Forecast for Parenteral Nutrition Market (Million US$), 2023 – 2027
Figure-27: Indication – Immunoglobulins Market (Million US$), 2017 – 2022
Figure-28: Indication – Forecast for Immunoglobulins Market (Million US$), 2023 – 2027
Figure-29: Indication – Others Market (Million US$), 2017 – 2022
Figure-30: Indication – Forecast for Others Market (Million US$), 2023 – 2027
Figure-31: East North Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
Figure-32: East North Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
Figure-33: West South Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
Figure-34: West South Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
Figure-35: South Atlantica – Home Infusion Therapy Market (Million US$), 2017 – 2022
Figure-36: South Atlantica – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
Figure-37: North East – Home Infusion Therapy Market (Million US$), 2017 – 2022
Figure-38: North East – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
Figure-39: East South Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
Figure-40: East South Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
Figure-41: West North Centre – Home Infusion Therapy Market (Million US$), 2017 – 2022
Figure-42: West North Centre – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
Figure-43: Pacific Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
Figure-44: Pacific Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
Figure-45: Mountain States – Home Infusion Therapy Market (Million US$), 2017 – 2022
Figure-46: Mountain States – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
Figure-47: CVS Health – Global Revenue (Million US$), 2017 – 2022
Figure-48: CVS Health – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-49: Becton, Dickinson and Company – Global Revenue (Million US$), 2017 – 2022
Figure-50: Becton, Dickinson and Company – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-51: Smith & Nephew plc – Global Revenue (Million US$), 2017 – 2022
Figure-52: Smith & Nephew plc – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-53: Terumo Corporation – Global Revenue (Million US$), 2017 – 2022
Figure-54: Terumo Corporation – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-55: ICU Medical – Global Revenue (Million US$), 2017 – 2022
Figure-56: ICU Medical – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-57: Moog – Global Revenue (Million US$), 2017 – 2022
Figure-58: Moog – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-59: InfuSystems Holdings – Global Revenue (Million US$), 2017 – 2022
Figure-60: InfuSystems Holdings – Forecast for Global Revenue (Million US$), 2023 – 2027
List of Tables:
Table-01: United States – Home Infusion Therapy Market Share by Product (Percent), 2017 – 2022
Table-02: United States – Forecast for Home Infusion Therapy Market Share by Product (Percent), 2023 – 2027
Table-03: United States – Home Infusion Therapy Market Share by Product Type (Percent), 2017 – 2022
Table-04: United States – Forecast for Home Infusion Therapy Market Share by Product Type (Percent), 2023 – 2027
Table-05: United States – Home Infusion Therapy Market Share by Indication (Percent), 2017 – 2022
Table-06: United States – Forecast for Home Infusion Therapy Market Share by Indication (Percent), 2023 – 2027
Table-07: United States – Home Infusion Therapy Market Share by Zone (Percent), 2017 – 2022
Table-08: United States – Forecast for Home Infusion Therapy Market Share by Zone (Percent), 2023 – 2027

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us